Pharma Exclusives Pressreleases

Novogene Europe Expands Single-cell Sequencing Capability at Cambridge Omics Centre

Monday, July 27, 2026

Novogene Europe a multiomics research services partner today announced that it has expanded its singlecell RNA sequencing capability at its Cambridge Omics Centre This expansion brings singlecell sequencing

Lonza Acquires Rights to Nona Biosciences’ TfR1 Blood-Brain Barrier Technology and Expands Strategic Collaboration

Thursday, July 02, 2026

Lonza the worlds leading contract development and manufacturing organization CDMO today announced it has acquired the rights to Nona Biosciences Nona transferrin receptor TfR bloodbrain barrier

AlzeCure Pharma enters an out-licensing and collaboration agreement with QuantumCell ApS for the NeuroRestore ACD856 project

Wednesday, July 01, 2026

AlzeCure Pharma AB publ AlzeCure FN STO ALZCUR which develops smallmolecule drug candidates for CNS diseases with a focus on Alzheimers disease and pain announced today that the company

Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company

Wednesday, July 01, 2026

Lonza the worlds leading contract development and manufacturing organization CDMO today announced an expanded strategic collaboration with a leading USbased biopharmaceutical company

Provepharm launches Zyogreen® in the UK, first ready-to-use indocyanine green, fluorescent diagnostic dye for surgical visualisation and precision medicine

Wednesday, July 01, 2026

Provepharm a leading international pharmaceutical company specialising in medical dyes today announces the commercial launch of its licensed medicine Zyogreen a readytouse indocyanine green fluorescent imaging agent in the United Kingdom

Ipsen to acquire Kartos Therapeutics, expanding hemato-oncology late-stage pipeline

Monday, June 29, 2026

Ipsen and Kartos Therapeutics announced today they have entered into a definitive merger agreement under which Ipsen has agreed to acquire Kartos Therapeutics The acquisition adds navtemadlin an investigational MDM inhibitor

BioMed X and Servier Launch First Research Team in France to Pioneer AI-Driven Antibody Engineering

Thursday, April 16, 2026

BioMed X a leading innovation hub for pharma has officially launched its first research team at BioMed X France marking the establishment of its presence in one of Europes fastestgrowing life science ecosystems

Novo Nordisk and OpenAI partner to transform how medicines are discovered and delivered

Tuesday, April 14, 2026

Novo Nordisk today announced a strategic partnership with OpenAI that will place Novo Nordisk at the forefront of AI transformation in healthcare and help the company bring new and better treatment options to patients faster

Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements

Tuesday, April 14, 2026

Vetter a leading global Contract Development and Manufacturing Organization CDMO announced significant progress in the continued expansion of its global clinical manufacturing network With the ongoing scaleup

Touchlight Partners with SVF Vaccines to Advance Innovative Hepatitis B/D Vaccine to Clinic

Thursday, April 09, 2026

Touchlight a leading biotechnology company specialising in cellfree DNA manufacturing is proud to announce a strategic partnership with SVF Vaccines to progress SVFs innovative Hepatitis BD vaccine into clinical development